The FDA's Treatment of Structure/Function Claims under the Dietary Supplement Health
and Education Act

The FDA's Treatment of Structure/Function Claims under the Dietary Supplement Health and Education Act

DSpace/Manakin Repository

The FDA's Treatment of Structure/Function Claims under the Dietary Supplement Health and Education Act

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Powell, Karen J.	en_US
dc.date.accessioned	2012-12-07T16:21:31Z
dc.date.issued	2001	en_US
dc.identifier.citation	The FDA's Treatment of Structure/Function Claims under the Dietary Supplement Health and Education Act (2001 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:10015317
dc.description.abstract	Demand in the United States for dietary supplements and herbal products has exploded in past years. One report states that demand for dietary supplements has increased almost 50 percent since 1995.1 Congress, therefore, in response to the increased demand and other motivations (to be discussed below), has passed legislation intended to increase the amount and quality of information available to consumers in an e ort to maximize the bene ts of such products. Congress has attempted to develop a regulatory scheme in which an atmosphere of cooperation exists between the government, the dietary supplement industry and consumers of these products. However, it seems that Congress' intent in passing the Dietary Supplement Heath and Education Act (and related legislation) has not come to fruition.	en
dc.language.iso	en_US	en
dash.license	LAA
dc.subject	Food and Drug Law	en
dc.subject	FDA	en
dc.subject	DSHEA	en
dc.subject	dietary supplement	en
dc.title	The FDA's Treatment of Structure/Function Claims under the Dietary Supplement Health and Education Act	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-12-07T16:21:31Z